He said that there were small shifts in terms of the production of the necessary cytokines. The vaccine “Neooncovak” has triggered the production of cytokines—signaling proteins that play a crucial role in regulating and enhancing the immune response. According to Ginzburg, immunological results will be evaluated later, as the vaccine will be administered to the patient about ten more times.
In early April, "Neoonkovak" was first administered to a 60-year-old resident of the Kursk region with skin melanoma. The vaccine, made individually for each person, contains information about tumor-specific antigens, helping the immune system "identify" and attack even very small cancerous lesions. The cancer vaccine is expected to be included in free healthcare programs.
